Analysis of COVID-19 and Mucormycosis Infection in Vaccinated and Unvaccinated Individuals: A Cross-sectional Study

Introduction: Coronavirus Disease-2019 (COVID-19) pandemic unprecedentely led to health crisis in population across the globe. Even though the advent of vaccine has brought the spread of infection under control, shortage in vaccine supply, surge in breakthrough infections and associated mucormycosis...

Full description

Bibliographic Details
Main Authors: Kasturi Kshitija, Teeda Lakshmi Sri Naga Poojitha, Ande Dimple Sree Mounika, Deepak Rosha
Format: Article
Language:English
Published: JCDR Research and Publications Private Limited 2022-03-01
Series:Journal of Clinical and Diagnostic Research
Subjects:
Online Access:https://www.jcdr.net/articles/PDF/16114/53675_CE[Ra1]_F(KR)_PF1(AG_SS)_PFA(SHU)_PB(AG_SHU)_PN(SHU).pdf
_version_ 1811170780044591104
author Kasturi Kshitija
Teeda Lakshmi Sri Naga Poojitha
Ande Dimple Sree Mounika
Deepak Rosha
author_facet Kasturi Kshitija
Teeda Lakshmi Sri Naga Poojitha
Ande Dimple Sree Mounika
Deepak Rosha
author_sort Kasturi Kshitija
collection DOAJ
description Introduction: Coronavirus Disease-2019 (COVID-19) pandemic unprecedentely led to health crisis in population across the globe. Even though the advent of vaccine has brought the spread of infection under control, shortage in vaccine supply, surge in breakthrough infections and associated mucormycosis in immunosuppressed individuals posed a potential threat. Aim: To know the incidence and outcome of COVID-19 with superadded mucormycosis in vaccinated and unvaccinated people. Materials and Methods: The present cross-sectional study undertaken for a period of four months. April to July 2021 in the Department of Respiratory Medicine at Tertiary Care Hospital, New Delhi, India. Hospitalised COVID-19 patients were enrolled in the study. Details of age, gender and co-morbidities were taken into account. In COVID-19 with mucormycosis, glycosylated haemoglobin value and steroid therapy were also noted. Clinical outcome for all the cases were analysed. Statistical analysis of the data collected was done with Statistical Package for the Social Sciences (SPSS) version 20.0 software. Results: Out of 134 cases, 84 and 50 cases belonged to vaccinated and unvaccinated groups respectively. Isolated COVID-19 infection was noted in 102 cases and COVID-19 with mucormycosis in 32 cases. Diabetes mellitus and steroid therapy showed to be the predisposing factors for development of mucormycosis in COVID-19 cases. High proportion of unvaccinated individuals died due to isolated COVID-19 infection compared to vaccinated individuals and it was found to be statistically significant. Conclusion: To combat serious threats caused by the COVID-19 pandemic, complete vaccination which offers maximum protection is mandatory.
first_indexed 2024-04-10T17:02:19Z
format Article
id doaj.art-e16b51976f3c4060977df4f05ea5c511
institution Directory Open Access Journal
issn 2249-782X
0973-709X
language English
last_indexed 2024-04-10T17:02:19Z
publishDate 2022-03-01
publisher JCDR Research and Publications Private Limited
record_format Article
series Journal of Clinical and Diagnostic Research
spelling doaj.art-e16b51976f3c4060977df4f05ea5c5112023-02-06T09:10:11ZengJCDR Research and Publications Private LimitedJournal of Clinical and Diagnostic Research2249-782X0973-709X2022-03-01163EC19EC2210.7860/JCDR/2022/53675.16114Analysis of COVID-19 and Mucormycosis Infection in Vaccinated and Unvaccinated Individuals: A Cross-sectional StudyKasturi Kshitija0Teeda Lakshmi Sri Naga Poojitha1Ande Dimple Sree Mounika2Deepak Rosha3Associate Professor, Department of Pathology, Bhaskar Medical College and Bhaskar General Hospital, KNR University, Hyderabad, Telangana, India.Junior Resident, Department of Respiratory Medicine, Indraprastha Apollo Hospital, New Delhi, India.MBBS Student, Bhaskar Medical College and Bhaskar General Hospital, KNR University, Hyderabad, Telangana, India.Senior Consultant, Department of Respiratory Medicine, Critical Care and Sleep Medicine, Indraprastha Apollo Hospital, New Delhi, India.Introduction: Coronavirus Disease-2019 (COVID-19) pandemic unprecedentely led to health crisis in population across the globe. Even though the advent of vaccine has brought the spread of infection under control, shortage in vaccine supply, surge in breakthrough infections and associated mucormycosis in immunosuppressed individuals posed a potential threat. Aim: To know the incidence and outcome of COVID-19 with superadded mucormycosis in vaccinated and unvaccinated people. Materials and Methods: The present cross-sectional study undertaken for a period of four months. April to July 2021 in the Department of Respiratory Medicine at Tertiary Care Hospital, New Delhi, India. Hospitalised COVID-19 patients were enrolled in the study. Details of age, gender and co-morbidities were taken into account. In COVID-19 with mucormycosis, glycosylated haemoglobin value and steroid therapy were also noted. Clinical outcome for all the cases were analysed. Statistical analysis of the data collected was done with Statistical Package for the Social Sciences (SPSS) version 20.0 software. Results: Out of 134 cases, 84 and 50 cases belonged to vaccinated and unvaccinated groups respectively. Isolated COVID-19 infection was noted in 102 cases and COVID-19 with mucormycosis in 32 cases. Diabetes mellitus and steroid therapy showed to be the predisposing factors for development of mucormycosis in COVID-19 cases. High proportion of unvaccinated individuals died due to isolated COVID-19 infection compared to vaccinated individuals and it was found to be statistically significant. Conclusion: To combat serious threats caused by the COVID-19 pandemic, complete vaccination which offers maximum protection is mandatory.https://www.jcdr.net/articles/PDF/16114/53675_CE[Ra1]_F(KR)_PF1(AG_SS)_PFA(SHU)_PB(AG_SHU)_PN(SHU).pdfcoronavirus disease-2019outcomesuperadded infectionvaccination
spellingShingle Kasturi Kshitija
Teeda Lakshmi Sri Naga Poojitha
Ande Dimple Sree Mounika
Deepak Rosha
Analysis of COVID-19 and Mucormycosis Infection in Vaccinated and Unvaccinated Individuals: A Cross-sectional Study
Journal of Clinical and Diagnostic Research
coronavirus disease-2019
outcome
superadded infection
vaccination
title Analysis of COVID-19 and Mucormycosis Infection in Vaccinated and Unvaccinated Individuals: A Cross-sectional Study
title_full Analysis of COVID-19 and Mucormycosis Infection in Vaccinated and Unvaccinated Individuals: A Cross-sectional Study
title_fullStr Analysis of COVID-19 and Mucormycosis Infection in Vaccinated and Unvaccinated Individuals: A Cross-sectional Study
title_full_unstemmed Analysis of COVID-19 and Mucormycosis Infection in Vaccinated and Unvaccinated Individuals: A Cross-sectional Study
title_short Analysis of COVID-19 and Mucormycosis Infection in Vaccinated and Unvaccinated Individuals: A Cross-sectional Study
title_sort analysis of covid 19 and mucormycosis infection in vaccinated and unvaccinated individuals a cross sectional study
topic coronavirus disease-2019
outcome
superadded infection
vaccination
url https://www.jcdr.net/articles/PDF/16114/53675_CE[Ra1]_F(KR)_PF1(AG_SS)_PFA(SHU)_PB(AG_SHU)_PN(SHU).pdf
work_keys_str_mv AT kasturikshitija analysisofcovid19andmucormycosisinfectioninvaccinatedandunvaccinatedindividualsacrosssectionalstudy
AT teedalakshmisrinagapoojitha analysisofcovid19andmucormycosisinfectioninvaccinatedandunvaccinatedindividualsacrosssectionalstudy
AT andedimplesreemounika analysisofcovid19andmucormycosisinfectioninvaccinatedandunvaccinatedindividualsacrosssectionalstudy
AT deepakrosha analysisofcovid19andmucormycosisinfectioninvaccinatedandunvaccinatedindividualsacrosssectionalstudy